Women's hearts beat differently: Why heart disease is so often overlooked in women
From atypical heart attack symptoms to MINOCA and menopause as a cardiovascular turning point, all the way to the treatment gap after diagnosis: an evidence-based look at what studies really show about women’s heart health.
In brief (TL;DR)
Cardiovascular disease is the leading cause of death in women as well – yet it is more frequently overlooked, diagnosed later, and treated less often in accordance with guidelines than in men. A central reason: During a heart attack, women more often experience atypical symptoms such as nausea, back pain, or upper abdominal pain instead of classic chest pain, and their coronary arteries often appear normal during examinations even when a true circulatory disorder is present (MINOCA, microvascular angina).
According to a statement by the American Heart Association, menopause is a particularly critical window: as estrogen levels drop, cholesterol levels, abdominal fat distribution, and vascular function often change more unfavorably than aging alone would explain. A history of pregnancy involving preeclampsia, miscarriage, or preterm birth is also among the most underestimated risk factors.
Studies also show a treatment gap after diagnosis: compared to men with comparable or higher risk, women are less likely to receive high-dose statins, less likely to undergo cardiac catheterization, and less likely to be referred to cardiac rehabilitation.
The scientifically sound approach is therefore not a wellness promise, but education: knowing your own symptoms and risk factors, taking warning signs seriously, building an evidence-based prevention routine – and calling emergency services immediately if a heart attack is suspected, regardless of how "atypical" the symptoms may seem.
Important medical notice
This article provides health information and does not replace examination by a cardiologist, general practitioner, or emergency medical services. Cardiovascular diseases are potentially life-threatening.
In the event of sudden chest tightness, shortness of breath, pain in the arm, jaw, or back, cold sweats, nausea, or a severe feeling of illness – even without classic chest pain – the rule is: call emergency services (in Germany, Austria, and Switzerland: 112) immediately. Lifestyle measures, nutrients, and dietary supplements are no substitute for emergency medical evaluation or medically prescribed therapy (e.g., statins, blood pressure medication, antiplatelet agents) and must not delay or replace treatment that has already begun.
All nutrients and dietary supplements mentioned in this article are general dietary components; they are not drugs and are not a treatment for an existing cardiovascular disease.
Why heart disease is so often overlooked in women
In the public eye, cardiovascular disease is often viewed as a "man's disease." The reality is different: according to the German Heart Foundation, more women (53 percent) than men (47 percent) die from cardiovascular disease – not because women's hearts are sicker, but because diagnosis, research, and care have been predominantly geared toward the male clinical picture for decades.
In 2024, the American Heart Association addressed this gap in a detailed policy paper and formulated a cross-sector "Call to Action": more prevention, more awareness, better access to diagnostics, and fairer care for women with cardiovascular disease.
→ Source: American Heart Association – Call to Action for Cardiovascular Disease in Women, Circulation
The research base itself is also unevenly distributed. An analysis of 1,079 cardiovascular studies from 2017 to 2023, published in the journal JAMA Network Open in 2025, found that women remain underrepresented in clinical trials – despite comparable disease prevalence. Dr. Lena Seegers, head of Germany's only specialized women's heart center at the University Hospital Frankfurt, puts it this way: when studies are conducted primarily on men, diagnostic criteria, threshold values, and therapy recommendations also tend to reflect male physiology.
→ Source: Apotheken Umschau – Why women with heart disease still face disadvantages
Different symptoms, different diagnoses: How a heart attack can manifest in women
The classic heart attack shown in awareness campaigns – radiating pain in the left chest, like a vise – applies only partially to many women. Women more frequently report nausea, vomiting, back or upper abdominal pain, extreme fatigue, shortness of breath, or a vague feeling of being unwell – symptoms that have not historically been considered "typical" signs of a heart attack and are therefore more frequently misinterpreted, for example as digestive problems or fatigue.
Dr. Lisa Dannenberg, a cardiologist and researcher at the University Hospital Düsseldorf, also points to a care gap in acute cases: in emergency situations, men are significantly more likely to seek medical help immediately (42 percent) outside of regular office hours than women (28 percent) – a difference that can cost valuable time, as every minute counts when saving heart muscle tissue during a heart attack.
→ Source: Apotheken Umschau – Women's Heart Health
VeyT Symptom Note
"Atypical" does not mean "harmless." If you suddenly feel extremely fatigued, short of breath, nauseous, or just "wrong" and have an increased cardiovascular risk (e.g., high blood pressure, diabetes, smoking, family history, menopause), this is a reason for prompt medical evaluation – when in doubt, via emergency services.
MINOCA and microvascular angina: When the major coronary arteries look "clean"
Another finding that is central to women's cardiac medicine concerns the diagnostics themselves. A classic heart catheter checks for narrowings in the large coronary arteries. In many women with clear signs of a heart attack, however, this catheter shows no significant blockage – even though a circulatory disorder of the heart is actually present. This condition is referred to as MINOCA (Myocardial Infarction with Non-Obstructive Coronary Arteries) or, in the case of chronic complaints without a heart attack, as microvascular angina: what is affected here are the heart's smallest blood vessels, which a standard heart catheter does not reliably visualize.
Prof. C. Noel Bairey Merz, director of the Barbra Streisand Women's Heart Center at Cedars-Sinai Medical Center in Los Angeles and one of the world's most influential researchers on this topic, co-founded the long-term WISE study (Women's Ischemia Syndrome Evaluation), which established that ischemic heart diseases without visible vascular narrowing occur significantly more often in women than previously assumed and are associated with an independent, relevant risk for future heart events.
→ Sources: PubMed – Ischemia and No Obstructive Coronary Arteries (INOCA): A Narrative Review · PubMed – INOCA and MINOCA: Are Women's Heart Centres the Answer?
A review published in the journal Cureus in 2025 provides perspective on the scale: according to the review, MINOCA accounts for about 6 to 8 percent of all heart attacks – yet women account for over 70 percent of these cases. At the same time, the same analysis showed that women undergoing examination for chest pain receive unremarkable or non-obstructive coronary findings significantly more often (around 65 percent) than men (around 30 percent) – a finding that, without knowledge of MINOCA and microvascular angina, can be mistakenly interpreted as "no heart problem."
→ Source: El Bassiri et al., Gender Disparities in Ischemic Heart Disease Management, Cureus (2025)
The treatment gap after diagnosis
The differences do not end at the diagnosis. The same 2025 Cureus review summarizes several care studies and shows a consistent treatment gap following a confirmed heart attack: women are about 15.8 percent less likely to receive high-dose statins, 10 to 20 percent less likely to be referred for cardiac catheterization or PCI (balloon angioplasty/stent) following a STEMI heart attack, and 36 percent less likely to be referred to cardiac rehabilitation – and are also more likely to drop out of rehab prematurely.
→ Source: El Bassiri et al., Gender Disparities in Ischemic Heart Disease Management, Cureus (2025)
Prof. Ute Seeland, specialist physician and board member of the German Society for Gender-Specific Medicine, adds another often-overlooked aspect: women metabolize many cardiovascular medications differently than men. At the same dosage, therapeutic blood levels and side effect rates can differ – a reason why dosage regimens that were predominantly tested on men are not automatically optimal for women.
→ Source: German Heart Foundation (herzmedizin.de) – Heart health: What differentiates women and men
Evidence Visual: Where the treatment gap is largest
All values are taken from the above-cited Cureus review (2025) on care differences in ischemic heart disease.
Menopause as a cardiovascular turning point
One reason why heart health only becomes noticeably important to women in midlife lies in menopause itself. As long as the ovaries produce sufficient estrogen, women benefit from a certain cardiovascular protective effect. With the menopausal transition phase, this protection diminishes.
A scientific statement by the American Heart Association led by Dr. Samar El Khoudary (University of Pittsburgh) describes this transition as an independent cardiovascular risk window: cholesterol levels and the risk of metabolic syndrome rise more sharply than aging alone would explain, the ratio of "good" HDL cholesterol to heart risk partially reverses, and abdominal and visceral adipose tissue increases – an effect that, according to the statement, is associated with increased mortality from cardiovascular disease, cancer, and general causes, even in women with a normal BMI.
The statement also points to two practical figures: only about 7.2 percent of women in the menopausal transition meet physical activity recommendations, and less than 20 percent consistently maintain a healthy diet. Women who smoke also hit menopause about a year earlier on average – with a correspondingly earlier increase in risk.
→ Sources: El Khoudary et al., Menopause Transition and Cardiovascular Disease Risk, Circulation/AHA Scientific Statement (2020) · American Heart Association Newsroom – Heart Disease Risk Increases Leading Up to Menopause
Regarding hormone therapy, the statement notes that certain preparations can show cardiovascular benefits if started early in the menopausal transition – but not if menopause occurred significantly longer ago. Whether hormone therapy makes sense on an individual basis is a medical decision that considers age, timing of the last menstrual period, personal risk profile, and other conditions – this article does not replace this assessment. Anyone experiencing heart palpitations or racing heart during this phase can find guidance on warning signs, triggers, and evaluation in the article Cardiac arrhythmias in menopause: What studies show.
Pregnancy as an early warning system for the heart
A risk factor absent from many public awareness campaigns exists decades before the actual onset of heart disease: pregnancy history. According to analyses by the German Heart Foundation (Deutsche Herzstiftung), a miscarriage increases the subsequent risk of stroke by approximately 11 percent, and infertility by approximately 14 percent. Preeclampsia (pregnancy-induced high blood pressure with organ involvement) triples the long-term risk for coronary heart disease, and a premature birth resulting from this further increases that risk, according to the same source.
→ Source: Deutsche Herzstiftung (herzmedizin.de) – Heart Health: What Distinguishes Women and Men
The practical consequence: An obstetric history including preeclampsia, gestational diabetes, premature birth, repeated miscarriage, or infertility belongs in every subsequent cardiovascular risk discussion – regardless of how much time has passed since these events. However, many women never learn about this because obstetric care and subsequent primary care or cardiology management are rarely systematically linked.
Expert Perspectives & Protocol Breakdown
Prof. C. Noel Bairey Merz (Cedars-Sinai, WISE Study)
Focus on microvascular disease and MINOCA: A "clean" cardiac catheterization does not rule out ischemic heart disease in women. Specialized diagnostics (e.g., coronary reactivity testing) can be useful in unclear cases.
American Heart Association (Statements 2020 & 2024)
Focus on population level: Menopause is a window of opportunity for prevention; structural gaps in research, diagnostics, and care must be addressed both politically and clinically.
Prof. Ute Seeland (German Society for Gender-Specific Medicine)
Focus on medication dosage and daily care practice in Germany: Standard dosages and guidelines often require greater gender-specific differentiation.
Where all three perspectives meet
Heart health in women cannot be treated with the same standard assumptions as in men—neither in symptom recognition, nor in diagnostics, nor in follow-up care. All three perspectives rely on different but complementary evidence (basic/cohort research, systematic reviews, clinical practice) and do not contradict each other.
Evidence Map: Risk factors and what does not follow from them
| Factor | What studies show | Gender-specific characteristic | What does not follow |
|---|---|---|---|
| Menopause | Cholesterol, abdominal fat, and vascular function change in ways that are less favorable than can be explained by age alone | Independent AHA prevention window | Not every woman automatically develops heart disease |
| Preeclampsia / Preterm birth | Tripled long-term CHD risk | Detectable as a risk factor only in women | No automatism for every affected woman |
| Atypical symptoms | Nausea, back/upper abdominal pain, fatigue more frequently as leading symptoms | Higher risk of misinterpretation | Classic chest pain remains possible and important |
| MINOCA / microvascular angina | 6–8% of all infarcts, >70% of these in women | "Clean" cardiac catheterization does not reliably rule out an infarct | No reason to ignore symptoms |
| Magnesium | Meta-analysis: SBP −1.25 mmHg / DBP −1.40 mmHg on average, stronger at ≥400 mg/day | General nutritional component, no gender-specific verification | No substitute for blood pressure medication |
| Omega-3 | VITAL study: no effect on primary endpoint, but 28% fewer secondary heart attacks (exploratory) | Not specifically studied in women with heart disease | Secondary finding ≠ confirmed main effect |
| Vitamin D | VITAL study: no effect on major cardiovascular endpoints | Useful in case of proven deficiency, regardless of heart risk | No evidence-based prevention of heart attacks through high dosing |
The VeyT Prevention Framework for Women's Hearts
The American Heart Association bundles the most important, well-supported levers for heart health in "Life's Essential 8": diet, exercise, not smoking, sleep, weight management, cholesterol, blood sugar, and blood pressure. This framework applies to women and men equally—but for women, it must be supplemented with the specific features described in this article.
→ Source: American Heart Association – Life's Essential 8, Presidential Advisory, Circulation (2022)
Layer 1 – Knowledge
Know your own risk factors: blood pressure, cholesterol, blood sugar, family history, smoking status, pregnancy history, menopause status.
Layer 2 – Movement
Regular daily and endurance activity, especially during the menopause transition when physical activity often decreases.
Layer 3 – Nutrition
Vegetables, fruit, fiber, fish/Omega-3 sources, fewer highly processed foods and sugar.
Layer 4 – Sleep & Stress
Sleep quality and stress levels are independent heart risk factors, not just "wellness" topics.
Layer 5 – Control values
Have blood pressure, cholesterol, and blood sugar checked by a doctor regularly—especially from perimenopause onwards.
Layer 6 – Supplement nutrition purposefully
Magnesium, Omega-3, and Vitamin D can be meaningful additions to an already good diet—but they replace neither exercise nor medical treatment.
VeyT Nutritional Recommendations for this topic
For this article, we recommend as VeyT products exclusively Omega-3, Magnesium, and Vitamin D3/K2—general nutritional building blocks that were examined in the studies cited above in the context of cardiovascular parameters. They are not a treatment for an existing heart disease and no substitute for medically prescribed medications.
2000mg
Veyt™ Premium Omega-3 Complex
Fish oil capsules with 2,000 mg Omega-3 fatty acids per serving according to current product labeling. Categorized in the context of this article as a general nutritional building block—the VITAL study found no confirmed effect on the primary cardiovascular endpoint, but an exploratory reduction in heart attacks as a secondary finding.
View Veyt™ Premium Omega-3 Complex →SIUM
Veyt™ Multi-Magnesium Bio-Complex
Four-fold magnesium complex based on magnesium bisglycinate. A meta-analysis published in 2024 found an average blood pressure reduction of approximately 1.25 mmHg systolic and 1.40 mmHg diastolic with magnesium supplementation—more pronounced at dosages of 400 mg/day or more. Not a substitute for medically prescribed blood pressure therapy.
View Veyt™ Multi-Magnesium Bio-Complex →+ K2
Veyt™ Lumina D3 K2
Vitamin D3/K2 drops with 1,000 I.U. D3 and 20 µg K2 (MK7 all-trans) per drop according to current product labeling. Useful in case of proven vitamin D deficiency; however, the VITAL study found no confirmed effect of vitamin D supplementation on major cardiovascular endpoints in the general population.
View Veyt™ Lumina D3 K2 →Dietary supplements should not be considered a substitute for a balanced diet or medically prescribed therapy. If you have an existing cardiovascular disease, are taking blood thinners or other long-term medication, or are pregnant or breastfeeding, supplementation should be clarified with a doctor beforehand.
Checklist: When to act immediately – and what you can keep an eye on yourself
Call emergency services (112) immediately in case of:
□ Sudden pressure, tightness, or pain in the chest
□ Pain radiating into the arm, jaw, back, or upper abdomen
□ Sudden shortness of breath, cold sweat, nausea, or dizziness
□ A sudden, inexplicable "feeling of illness," especially with an elevated heart risk
Regular medical check-ups:
□ Blood pressure, cholesterol, and blood sugar – at least annually from 40, earlier if there are risk factors
□ Discuss menopause status and individual risk during the transition to menopause
□ Actively bring up pregnancy history (preeclampsia, preterm birth, miscarriage), even years later
□ For unclear chest pain with a "normal" cardiac catheterization: specifically ask about MINOCA/microvascular angina
What has not yet been sufficiently proven?
Two points deserve special caution. First: The cardioprotective effects of Omega-3 and Vitamin D from observational studies have not been confirmed for the general population in the large, randomized VITAL study—the observed reduction of heart attacks with Omega-3 was a secondary, exploratory finding and not a confirmed primary effect. Second: Most gender-specific care data come from the USA and Germany; how exactly diagnostic and treatment gaps appear in other European healthcare systems is less well researched.
Editorial Verdict: Heart health requires a separate view for women
First: Cardiovascular diseases are at least as relevant for women as they are for men—in Germany, they are even the more frequent cause of death among the two sexes.
Second: Symptoms, diagnostics, and treatment sometimes follow different patterns in women—atypical complaints, MINOCA, microvascular angina, and a documented treatment gap after diagnosis are part of this.
Third: Menopause and one's own pregnancy history are two of the most underestimated points in time for a cardiovascular risk assessment.
Fourth: Diet, exercise, sleep, and targeted nutrients such as magnesium, Omega-3, and Vitamin D can meaningfully support a good prevention routine—but they replace neither medical diagnostics nor prescribed therapy.
Fifth: The most important first step is often the simplest: know your own symptoms, risk factors, and pregnancy history – and when in doubt, it is better to call emergency services once too early than too late.
Frequently Asked Questions About Women's Heart Health
Why are heart diseases in women so often overlooked?
Because clinical research, diagnostic criteria, and awareness campaigns have historically been predominantly oriented toward the male clinical profile, whereas women more frequently exhibit atypical symptoms and normal cardiac catheterization findings in the presence of actual blood flow disorders.
Which heart attack symptoms are typical for women?
In addition to classic chest pain, women more frequently experience nausea, vomiting, back or upper abdominal pain, extreme fatigue, shortness of breath, or a diffuse feeling of illness.
What is MINOCA?
MINOCA stands for myocardial infarction with non-obstructive coronary arteries during cardiac catheterization. It accounts for about 6 to 8 percent of all heart attacks but disproportionately affects women.
Why does menopause increase heart risk?
As estrogen levels decline, cholesterol levels, abdominal fat distribution, and vascular function change more unfavorably than aging alone would explain – an effect described by the American Heart Association in its own scientific statement.
Does preeclampsia increase future heart risk?
Yes. According to evaluations by the German Heart Foundation (Deutsche Herzstiftung), preeclampsia triples the long-term risk of coronary heart disease; a resulting preterm birth further increases this risk.
Are women treated differently than men after a heart attack?
Studies show that after a heart attack, women are less likely than men to receive high-dose statins, undergo cardiac catheterization, or be referred to cardiac rehabilitation.
Can magnesium lower blood pressure?
A 2024 meta-analysis found an average blood pressure reduction of about 1.25 mmHg systolic and 1.40 mmHg diastolic through magnesium supplementation, with more significant effects at higher doses. This does not replace medically prescribed blood pressure therapy.
Does Omega-3 help prevent heart attacks?
The large VITAL study found no definitive effect on the primary cardiovascular endpoint, but it did show an exploratory, secondary reduction in heart attacks with Omega-3 supplementation.
Does Vitamin D protect the heart?
According to the VITAL study, Vitamin D supplementation in the general population showed no definitive effect on major cardiovascular endpoints. Correcting a proven deficiency remains advisable.
When should I call emergency services if I suspect a heart attack?
Immediately – in the event of sudden chest tightness, radiating pain, shortness of breath, cold sweat, nausea, or a severe, unexplained feeling of illness, regardless of how "atypical" the symptoms may appear.
References & Scientific Citations
- American Heart Association – Call to Action for Cardiovascular Disease in Women, Circulation (2024)
- El Khoudary et al. – Menopause Transition and Cardiovascular Disease Risk, Circulation/AHA Scientific Statement (2020)
- American Heart Association Newsroom – Heart Disease Risk Increases Leading Up to Menopause
- American Heart Association – Life's Essential 8, Presidential Advisory, Circulation (2022)
- El Bassiri et al. – Gender Disparities in Ischemic Heart Disease Management, Cureus (2025)
- PubMed – Ischemia and No Obstructive Coronary Arteries (INOCA): A Narrative Review
- PubMed – INOCA and MINOCA: Are Women's Heart Centres the Answer?
- C. Noel Bairey Merz, MD – Cedars-Sinai Barbra Streisand Women's Heart Center
- Alharran et al. – Impact of Magnesium Supplementation on Blood Pressure: An Umbrella Meta-Analysis, Current Therapeutic Research (2024)
- Manson et al. – Marine n-3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer (VITAL), NEJM (2019)
- Manson et al. – Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease (VITAL), NEJM (2019)
- Apotheken Umschau – Why women with heart disease still face disadvantages
- German Heart Foundation (herzmedizin.de) – Heart health: The differences between women and men
- Veyt™ – Premium Omega-3 Complex
- Veyt™ – Multi-Magnesium Bio-Complex
- Veyt™ – Lumina D3 K2
Source Transparency: Clinical statements regarding the diagnosis, risk, and treatment of cardiovascular diseases in women are primarily categorized in this article based on statements from the American Heart Association, the German Heart Foundation, as well as peer-reviewed studies and systematic reviews. Expert perspectives, observational data, and randomized study results are not treated as equivalent.
